1998
DOI: 10.1016/s0022-2143(98)90022-1
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of 11β-hydroxysteroid dehydrogenase by bioflavonoids and their interaction with furosemide and gossypol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2004
2004
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(4 citation statements)
references
References 23 publications
0
4
0
Order By: Relevance
“…According to several workers (Zhang & Wang, 1997;Guo & Reidenberg, 1998;Wang et al, 2002), flavonoids inhibit the action of 11βHSD2. This enzyme, localized to mineralocorticoid target cells in the kidney, colon and parotid glands as well as to the pancreas and placenta (Mercer & Krozowski, 1992;Brown et al, 1993;Albiston et al, 1994) was identified as the enzymatic "gatekeeper" that catalyses the conversion of the active glucocorticoid into the inactive form, thus excluding active glucocorticoids from the non-specific mineralocorticoid receptors which display little inherent specificity for their normal ligand, aldosterone (Krozowski & Funder, 1983;Arriza et al, 1987).…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…According to several workers (Zhang & Wang, 1997;Guo & Reidenberg, 1998;Wang et al, 2002), flavonoids inhibit the action of 11βHSD2. This enzyme, localized to mineralocorticoid target cells in the kidney, colon and parotid glands as well as to the pancreas and placenta (Mercer & Krozowski, 1992;Brown et al, 1993;Albiston et al, 1994) was identified as the enzymatic "gatekeeper" that catalyses the conversion of the active glucocorticoid into the inactive form, thus excluding active glucocorticoids from the non-specific mineralocorticoid receptors which display little inherent specificity for their normal ligand, aldosterone (Krozowski & Funder, 1983;Arriza et al, 1987).…”
Section: Discussionmentioning
confidence: 98%
“…Since glucocorticoids induce the expression of milk proteins such as casein and lactalbumin (Ono & Oka, 1980), the postpartum decrease in 11βHSD2 activity, and hence increased active glucocorticoids, is a prerequisite for the endocrine induction of lactation (Quirk et al, 1990). The report by several workers that flavonoids inhibit the activity of 11βHSD2 (Zhang & Wang, 1997;Guo & Reidenberg, 1998;Wang et al, 2002) suggests that consumption of aqueous extract of HS, reported to be rich in flavonoids (Dafallah & Al-Mustafa, 1996;Appel, 2003;Adigun et al, 2006), during lactation, further increases the concentration of active glucocorticoids. This may explain the increased corticosterone level as observed in the present study.…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, there was increased maternal plasma glucocorticoid level possibly due to the osmotic and nutrient stresses in the HS dams as a result of the HS-induced increase in plasma Na + concentration (Iyare and Adegoke, 2008). In addition, the flavonoids in the HS extract have been shown to inhibit the activity of 11βOHSD-2 (Wand et al, 2002;Guo and Reidenberg, 1998;Zhang and Wang, 1997;Lee et al, 1996). This greatly reduces the conversion of the active glucocorticoid to the inactive form and thus increases the level of glucocorticoid reaching the foetus.…”
Section: Discussionmentioning
confidence: 99%
“…The increase in body weight could be attributed to the following: the developing foetuses of the Hs dams might have mustered adaptive mechanisms to safeguard their growth and development [19,20], and/or the malnutrition in the Hs dams that started early in pregnancy may have prompted placental development that may have favoured elevated nutrient delivery to the growing foetuses [21][22][23], lastly, the flavonoid constituent of Hs might have directly influenced the growth of the foetuses, as flavonoids have demonstrated direct growth promoting effect [24]. Moreover, the flavonoids in the Hs extract could have inhibited the activity of 11β-hydroxysteroid dehydrogenase type 2 (11βHSD-2) [25][26][27]. This greatly reduces the conversion of the active glucocorticoid to the inactive form and thus increases the level of glucocorticoid reaching the foetus.…”
Section: Discussionmentioning
confidence: 99%